Prevalence of Osteoporosis in Korean Prostate Cancer Patients Who is Receiving LHRH Agonist and/or Anti-androgen Agent
NCT01025479
·
clinicaltrials.gov ↗
COMPLETED
Status
829
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Osteoporosis
Sponsor
AstraZeneca